MD HB1481

Prohibits tissue banks and hospitals from denying physician-ordered autologous blood donations (patient's own blood stored for future use) or directed blood donations (from a designated donor) solely based on internal policy, provided all safety, testing, and regulatory requirements are met.

Allows patients or their authorized medical decision-makers to request autologous or directed blood donations for planned medical procedures when ordered by the treating physician and medically appropriate.

Permits tissue banks and hospitals to decline requests only when compliance is not feasible due to medical, logistical, or regulatory constraints.

Requires tissue banks and hospitals to provide patients with clear information about available blood donation options consistent with informed consent standards.

Takes effect October 1, 2026, and does not require facilities to establish new donation programs, accept blood that fails safety standards, or interfere with emergency transfusion protocols.